Pharmacogenomics: Data, Policies and Personalized Medicine

This 90-minute webinar will help you understand the current landscape of the growing field of pharmacogenomics and the current regulatory efforts to ensure that the related drugs will not pose risks for patient safety and promote innovations.

 Why Should You Attend:

This 90-minute session will review the new and expected regulations/ technologies and discuss their effects on the use of pharmacogenomics in industry. We will explain what the policies are, predict coming regulations and discuss how industry will be affected. We will explore the personalized medicine landscape in US, EU and globally.

Areas Covered in the Seminar:

• Overview of Pharmacogenomics, applications and challenges.
• From Pharmacogenomics to Personalized Medicine.
• PharmacoGenomics Data, genetic tests and Biomarkers.
• FDA(US) guidances and federal initiatives(NIH, CDC, CMS).
• EMEA (EU), Health Canada guidances and global landscape.
• Clinical Genomics data standards (EHR, HL7, ISO, Healthcare).
• Drug/Healthcare industry and pharmacogenomics.
• Pharmacogenomics and Ethical issues.
• Future of Genomics Medicine.

Who Will Benefit:

• Senior Management
• Clinical research leaders & members
• Clinical Scientists
• Regulatory affairs
• R&D and engineering staff
• Risk Managers
• Academic genomics groups
• Compliance Officers